614 related articles for article (PubMed ID: 9436005)
1. Helicobacter pylori: beyond peptic ulcer disease.
Wisniewski RM; Peura DA
Gastroenterologist; 1997 Dec; 5(4):295-305. PubMed ID: 9436005
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
3. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
4. [Crucial roles of Helicobacter pylori infection in the pathogenesis of gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma].
Ota H; Asano N; Yamauchi K; Akamatsu T
Rinsho Byori; 2009 Sep; 57(9):861-9. PubMed ID: 19860212
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori in solid-organ transplant recipient.
Ueda Y; Chiba T
Curr Opin Organ Transplant; 2008 Dec; 13(6):586-91. PubMed ID: 19060547
[TBL] [Abstract][Full Text] [Related]
7. Association of Helicobacter pylori with gastroduodenal diseases.
Hirai Y; Hayashi S; Shimomura H; Oguma K; Yokota K
Jpn J Infect Dis; 1999 Oct; 52(5):183-97. PubMed ID: 10680084
[TBL] [Abstract][Full Text] [Related]
8. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
9. [Helicobacter pylori and ulcer disease: diagnosis and treatment 1995].
Kayser S; Fried M
Praxis (Bern 1994); 1996 Sep; 85(39):1197-200. PubMed ID: 8927903
[TBL] [Abstract][Full Text] [Related]
10. [Peptic ulcer disease and hemorrhagic gastritis with H. pylori infection].
Yamamoto I; Fukuda Y; Nakajima K; Kamimoto H; Tsuzuki Y; Shimoyama T
Nihon Rinsho; 1998 Sep; 56(9):2263-8. PubMed ID: 9780703
[TBL] [Abstract][Full Text] [Related]
11. [Helicobacter pylori, a risk factor for stomach cancer and primary stomach lymphoma?].
Raderer M; Scheithauer W
Wien Klin Wochenschr; 1994; 106(17):556-8. PubMed ID: 7975671
[TBL] [Abstract][Full Text] [Related]
12. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
13. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma.
Graham DY
Prev Med; 1994 Sep; 23(5):712-6. PubMed ID: 7845945
[TBL] [Abstract][Full Text] [Related]
14. The role of Helicobacter pylori in pathogenesis: the spectrum of clinical outcomes.
Hunt RH
Scand J Gastroenterol Suppl; 1996; 220():3-9. PubMed ID: 8898429
[TBL] [Abstract][Full Text] [Related]
15. [Helicobacter pylori in peptic ulcer and gastric cancer].
Matsukura N; Onda M; Yamashita K
Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
[TBL] [Abstract][Full Text] [Related]
16. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori and malignant diseases of the stomach].
Prskalo M; Sabarić B; Tićak M; Skurla B; Dominis M; Dzebro S; Gasparov S; Colić-Cvrlje V; Naumovski-Mihalić S; Filipec T; Papa B; Ljubanović D; Presecki V; Katicić M
Lijec Vjesn; 2002 Sep; 124 Suppl 1():57-60. PubMed ID: 12592819
[TBL] [Abstract][Full Text] [Related]
18. Long-term consequences of Helicobacter pylori eradication.
Tytgat GN
Scand J Gastroenterol Suppl; 1994; 205():38-44. PubMed ID: 7863240
[TBL] [Abstract][Full Text] [Related]
19. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
20. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
Akamatsu T; Mochizuki T; Okiyama Y; Matsumoto A; Miyabayashi H; Ota H
Helicobacter; 2006 Apr; 11(2):86-95. PubMed ID: 16579838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]